The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Short Interest Up 17.4% in February

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a large increase in short interest in February. As of February 28th, there was short interest totalling 13,500 shares, an increase of 17.4% from the February 13th total of 11,500 shares. Based on an average daily trading volume, of 30,900 shares, the days-to-cover ratio is currently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Stock Performance

Shares of NASDAQ:CGABL opened at $17.88 on Thursday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a one year low of $17.48 and a one year high of $20.85. The business’s fifty day moving average price is $18.11 and its two-hundred day moving average price is $18.92.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Saturday, February 15th. Stockholders of record on Saturday, February 1st were issued a dividend of $0.2891 per share. The ex-dividend date of this dividend was Friday, January 31st. This is an increase from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. This represents a $1.16 dividend on an annualized basis and a dividend yield of 6.47%.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Company Profile

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.